>>Description of the research protocol "CHUB-BPCO"

Impact de l'oxygénothérapie à haut débit sur le reconditionnement des BPCO gold IV en soins intensifs
Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Soins Intensifs
Brugmann identifier : CHUB-BPCO
EudraCT identifier : B077201733165


Involved department : Intensive care
Principal investigator : De Bels
Sponsor : CHU-TFE
Contact : Clinical Research Unit

>This protocol was approved by the Brugmann (monocentrique) ethics committee.